![]()
7/18/2012
ActiViews, Inc. Announces Partnership with NeuroLogica Corporation to Optimize Lung and Liver Interventions in a Standard Operating Room
Wakefield, MA ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced a partnership today with Danvers, MA-based NeuroLogica Corporation in order to develop an integratedREAD MORE
5/22/2012
ActiViews, Inc. Announces SFDA Clearance for CT-Guide® Needle Guidance System in China.
WAKEFIELD, Mass, ActiViews, Inc., a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today that China's State Food and Drug Administration (SFDA) has granted clearance to market CT-GuideREAD MORE
5/10/2012
ActiViews, Inc. Announces First Lung Procedure with CT-Guide® Needle Guidance System in the U.S.
WAKEFIELD, Mass, ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today the first successful procedure in the United States with CT-Guide navigation. The procedure wasREAD MORE
4/23/2012
ActiViews, Inc. Announces FDA 510(k) Clearance of CT-Guide® Needle Guidance System for Liver Interventions
WAKEFIELD, Mass. ActiViews, Inc., a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market itsREAD MORE
4/2/2012
The ActiViews CT-Guide® Navigation System Named as Finalist in the 2012 Medical Design Excellence Awards
WAKEFIELD, Mass, ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today that CT-Guide navigation has been selected as a finalist in the 2012 Medical Design ExcellenceREAD MORE
7/13/2011
ActiViews, Inc. Announces FDA 510(k) Clearance of CT-Guide® Needle Guidance System for Lung Interventions
WAKEFIELD, Mass, ActiViews, Inc., an early stage company pioneering the development of cost-effective interventional medical navigation instrumentation, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance toREAD MORE
![]()


